Immunocompromised patients, premature infants, critically ill individuals, those with central venous catheters, and patients with severe acute pancreatitis should avoid GLP-1 probiotics due to elevated risk of serious infections and adverse outcomes
Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P
Join online communities or local support groups, including NHS-recommended programs
Time-to-event analyses showed lower cumulative probabilities of pregnancy and live birth among semaglutide users, although hazard ratios were not consistently significant
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist drug, FDA-approved for type 2 diabetes mellitus (Ozempic and Rybelsus) and chronic weight management (Wegovy)
Disclaimer: This article is for informational purposes only, is not medical advice, and readers should consult a licensed healthcare provider before considering any of the compounds discussed here